Cellebrite DI Ltd. (CLBT) is a Software - Infrastructure company in the Technology sector, currently trading at $11.86. It has a SharesGrow Score of 71/100, indicating a above average investment profile with 4 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of CLBT = $55.26 (+365.9% from the current price, the stock appears undervalued). Analyst consensus target is CLBT = $21 (+74.3% upside).
Valuation: CLBT trades at a trailing Price-to-Earnings (P/E) of 43.4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.88.
Financials: revenue is $476M, +20.7%/yr average growth. Net income is $78M, growing at -96.1%/yr. Net profit margin is 16.5% (healthy). Gross margin is 84.2% (+2.9 pp trend).
Balance sheet: total debt is $23M against $484M equity (Debt-to-Equity (D/E) ratio 0.05, conservative). Current ratio is 1.56 (strong liquidity). Debt-to-assets is 2.4%. Total assets: $939M.
Analyst outlook: 8 / 8 analysts rate CLBT as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 49/100 (Partial), Growth 58/100 (Partial), Past 50/100 (Partial), Health 100/100 (Pass), Moat 70/100 (Pass), Future 100/100 (Pass), Income 70/100 (Pass).
